Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67


Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.

Cross AJ, Wooldrage K, Robbins EC, Kralj-Hans I, MacRae E, Piggott C, Stenson I, Prendergast A, Patel B, Pack K, Howe R, Swart N, Snowball J, Duffy SW, Morris S, von Wagner C, Halloran SP, Atkin WS.

Gut. 2019 Sep;68(9):1642-1652. doi: 10.1136/gutjnl-2018-317297. Epub 2018 Dec 11.


Effect of once-only flexible sigmoidoscopy screening on the outcomes of subsequent faecal occult blood test screening.

Brown JP, Wooldrage K, Kralj-Hans I, Wright S, Cross AJ, Atkin WS.

J Med Screen. 2019 Mar;26(1):11-18. doi: 10.1177/0969141318785654. Epub 2018 Oct 3.


High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.

Brown JP, Wooldrage K, Wright S, Nickerson C, Cross AJ, Atkin WS.

J Med Screen. 2018 Jun;25(2):70-75. doi: 10.1177/0969141317698501. Epub 2017 May 3.


British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.

East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, Leedham SJ, Phull PS, Rutter MD, Shepherd NA, Tomlinson I, Rees CJ.

Gut. 2017 Jul;66(7):1181-1196. doi: 10.1136/gutjnl-2017-314005. Epub 2017 Apr 27. Review.


Erratum to: Appearances of screen-detected versus symptomatic colorectal cancers at CT colonography.

Plumb AA, Pathiraja F, Nickerson C, Wooldrage K, Burling D, Taylor SA, Atkin WS, Halligan S.

Eur Radiol. 2016 Dec;26(12):4323-4324. No abstract available.


Appearances of screen-detected versus symptomatic colorectal cancers at CT colonography.

Plumb AA, Pathiraja F, Nickerson C, Wooldrage K, Burling D, Taylor SA, Atkin WS, Halligan S.

Eur Radiol. 2016 Dec;26(12):4313-4322. Epub 2016 Apr 5. Erratum in: Eur Radiol. 2016 Dec;26(12 ):4323-4324.


Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer.

Young GP, Senore C, Mandel JS, Allison JE, Atkin WS, Benamouzig R, Bossuyt PM, Silva MD, Guittet L, Halloran SP, Haug U, Hoff G, Itzkowitz SH, Leja M, Levin B, Meijer GA, O'Morain CA, Parry S, Rabeneck L, Rozen P, Saito H, Schoen RE, Seaman HE, Steele RJ, Sung JJ, Winawer SJ.

Cancer. 2016 Mar 15;122(6):826-39. doi: 10.1002/cncr.29865. Epub 2016 Feb 1.


European Code against Cancer, 4th Edition: Cancer screening.

Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS, Dean PB, de Koning HJ, Dillner L, Herrero R, Kuipers EJ, Lansdorp-Vogelaar I, Minozzi S, Paci E, Regula J, Törnberg S, Segnan N.

Cancer Epidemiol. 2015 Dec;39 Suppl 1:S139-52. doi: 10.1016/j.canep.2015.10.021.


CT colonography for diagnosis of symptomatic colorectal cancer: the SIGGAR trials and their implication for service delivery.

Halligan S, Atkin WS.

Clin Radiol. 2013 Jul;68(7):643-5. doi: 10.1016/j.crad.2013.02.008. Epub 2013 Apr 3. No abstract available.


Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability.

Irving GR, Howells LM, Sale S, Kralj-Hans I, Atkin WS, Clark SK, Britton RG, Jones DJ, Scott EN, Berry DP, Hemingway D, Miller AS, Brown K, Gescher AJ, Steward WP.

Cancer Prev Res (Phila). 2013 Feb;6(2):119-28. doi: 10.1158/1940-6207.CAPR-12-0281. Epub 2012 Dec 11.


European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Quality assurance in endoscopy in colorectal cancer screening and diagnosis.

Valori R, Rey JF, Atkin WS, Bretthauer M, Senore C, Hoff G, Kuipers EJ, Altenhofen L, Lambert R, Minoli G; International Agency for Research on Cancer.

Endoscopy. 2012 Sep;44 Suppl 3:SE88-105. Epub 2012 Sep 25.


European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Colonoscopic surveillance following adenoma removal.

Atkin WS, Valori R, Kuipers EJ, Hoff G, Senore C, Segnan N, Jover R, Schmiegel W, Lambert R, Pox C; International Agency for Research on Cancer.

Endoscopy. 2012 Sep;44 Suppl 3:SE151-63. Epub 2012 Sep 25.


Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C; SCORE Working Group.

J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22. doi: 10.1093/jnci/djr284. Epub 2011 Aug 18. Erratum in: J Natl Cancer Inst. 2011 Dec 21;103(24):1903. Fracchia, M [added].


Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network.

Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P; International Colorectal Cancer Screening Network.

Int J Cancer. 2012 Jun 15;130(12):2961-73. doi: 10.1002/ijc.26310. Epub 2011 Aug 30.


Improving colorectal cancer screening outcomes: proceedings of the second meeting of the International Colorectal Cancer Screening Network, a global quality initiative.

Atkin WS, Benson VS, Green J, Monk CR, Nadel MR, Patnick J, Smith RA, Villain P.

J Med Screen. 2010;17(3):152-7. doi: 10.1258/jms.2010.010002.


The impact of individually-tailored lifestyle advice in the colorectal cancer screening context: a randomised pilot study in North-West London.

Robb KA, Power E, Kralj-Hans I, Atkin WS, Wardle J.

Prev Med. 2010 Dec;51(6):505-8. doi: 10.1016/j.ypmed.2010.10.002. Epub 2010 Oct 13.


Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators.

Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X. Epub 2010 Apr 27.


Perceived barriers to flexible sigmoidoscopy screening for colorectal cancer among UK ethnic minority groups: a qualitative study.

Austin KL, Power E, Solarin I, Atkin WS, Wardle J, Robb KA.

J Med Screen. 2009;16(4):174-9. doi: 10.1258/jms.2009.009080.


The psychological impact of being offered surveillance colonoscopy following attendance at colorectal screening using flexible sigmoidoscopy.

Miles A, Atkin WS, Kralj-Hans I, Wardle J.

J Med Screen. 2009;16(3):124-30. doi: 10.1258/jms.2009.009041.


Choosing between CT colonography and colonoscopy in the diagnostic context: a qualitative study of influences on patient preferences.

von Wagner C, Halligan S, Atkin WS, Lilford RJ, Morton D, Wardle J.

Health Expect. 2009 Mar;12(1):18-26. doi: 10.1111/j.1369-7625.2008.00520.x.


Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network.

Int J Cancer. 2008 Mar 15;122(6):1357-67.


Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-up.

Cafferty FH, Wong JM, Yen AM, Duffy SW, Atkin WS, Chen TH.

Cancer J. 2007 Jul-Aug;13(4):263-70.


Role of NQO1C609T and EPHX1 gene polymorphisms in the association of smoking and alcohol with sporadic distal colorectal adenomas: results from the UKFSS Study.

Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop DT, Primrose J, Bingham SA.

Carcinogenesis. 2007 Apr;28(4):875-82. Epub 2006 Nov 1.


MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK Flexible Sigmoidoscopy Screening Trial (United Kingdom).

Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop TD, Primrose J, Bingham SA.

Cancer Causes Control. 2006 Aug;17(6):793-801.


Effective screening for bowel cancer: a United kingdom perspective.

Thompson MR, Steele RJ, Atkin WS.

Dis Colon Rectum. 2006 Jun;49(6):895-908.


Impending or pending? The national bowel cancer screening programme.

Atkin WS.

BMJ. 2006 Apr 1;332(7544):742. Epub 2006 Mar 22. No abstract available.


Colonoscopic screening of women for colorectal neoplasia.

Levin TR, Atkin WS.

N Engl J Med. 2005 Aug 25;353(8):844-6; author reply 844-6. No abstract available.


No association between cytochrome P450 and glutathione S-transferase gene polymorphisms and risk of colorectal adenoma: results from the UK Flexible Sigmoidoscopy Screening Trial.

Gunter MJ, Watson MA, Loktionov AS, Mitrou P, Cecil T, Macklin C, Cardwell C, Bishop DT, Primrose J, Atkin WS, Bingham SA.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1028-30. No abstract available.


The effect of cigarette smoking use and cessation on serum insulin-like growth factors.

Renehan AG, Atkin WS, O'dwyer ST, Shalet SM.

Br J Cancer. 2004 Oct 18;91(8):1525-31.


Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population.

Ferraris R, Senore C, Fracchia M, Sciallero S, Bonelli L, Atkin WS, Segnan N; SCORE Working Group, Italy.

Eur J Cancer. 2004 Jan;40(2):245-52.


Identifying and managing patients at low risk of bowel cancer in general practice.

Thompson MR, Heath I, Ellis BG, Swarbrick ET, Wood LF, Atkin WS.

BMJ. 2003 Aug 2;327(7409):263-5. Review. No abstract available.


Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom.

Whynes DK, Frew EJ, Edwards R, Atkin WS.

Int J Technol Assess Health Care. 2003 Spring;19(2):384-95.


Effect of hysterectomy status on polyp detection rates at screening flexible sigmoidoscopy.

Adams C, Cardwell C, Cook C, Edwards R, Atkin WS, Morton DG.

Gastrointest Endosc. 2003 Jun;57(7):848-53.


An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.

Jaeger EE, Woodford-Richens KL, Lockett M, Rowan AJ, Sawyer EJ, Heinimann K, Rozen P, Murday VA, Whitelaw SC, Ginsberg A, Atkin WS, Lynch HT, Southey MC, Debinski H, Eng C, Bodmer WF, Talbot IC, Hodgson SV, Thomas HJ, Tomlinson IP.

Am J Hum Genet. 2003 May;72(5):1261-7. Epub 2003 Apr 14.


Protagonist: population based endoscopic screening for colorectal cancer.

Atkin WS, Northover JM.

Gut. 2003 Mar;52(3):321-2. Review. No abstract available.


Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.

Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M, Atkin WS; SCORE Working Group--Italy.

J Natl Cancer Inst. 2002 Dec 4;94(23):1763-72.


The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM, Todd IP.

Histopathology. 2002 Sep;41(3A):59-81. No abstract available.


Surveillance guidelines after removal of colorectal adenomatous polyps.

Atkin WS, Saunders BP; British Society for Gastroenterology; Association of Coloproctology for Great Britain and Ireland.

Gut. 2002 Oct;51 Suppl 5:V6-9. No abstract available.


Total colonic dye-spray increases the detection of diminutive adenomas during routine colonoscopy: a randomized controlled trial.

Brooker JC, Saunders BP, Shah SG, Thapar CJ, Thomas HJ, Atkin WS, Cardwell CR, Williams CB.

Gastrointest Endosc. 2002 Sep;56(3):333-8.


Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial.

Atkin WS, Cook CF, Cuzick J, Edwards R, Northover JM, Wardle J; UK Flexible Sigmoidoscopy Screening Trial Investigators.

Lancet. 2002 Apr 13;359(9314):1291-300. Erratum in: Lancet. 2010 Jun 19;375(9732):2142. Atkin, W S [added]; Cook, C F [added]; Cuzick, J [added]; Edwards, R [added]; Northover, J M A [added]; Wardle, J [added].


Risk of colorectal neoplasia in acromegaly: an independent view.

Atkin WS.

Clin Endocrinol (Oxf). 2001 Dec;55(6):723-5. No abstract available.


Rectal retroflexion: an essential part of lower gastrointestinal endoscopic examination.

Hanson JM, Atkin WS, Cunliffe WJ, Browell DA, Griffith CD, Varma JS, Plusa SM.

Dis Colon Rectum. 2001 Nov;44(11):1706-8.


Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening.

Atkin WS, Edwards R, Wardle J, Northover JM, Sutton S, Hart AR, Williams CB, Cuzick J.

J Med Screen. 2001;8(3):137-44.


Microsatellite instability: application in hereditary non-polyposis colorectal cancer.

Saletti P, Edwin ID, Pack K, Cavalli F, Atkin WS.

Ann Oncol. 2001 Feb;12(2):151-60. Review.


High-risk colorectal adenomas and serum insulin-like growth factors.

Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM, O'Dwyer ST.

Br J Surg. 2001 Jan;88(1):107-13.


Circulating insulin-like growth factor II and colorectal adenomas.

Renehan AG, Painter JE, O'Halloran D, Atkin WS, Potten CS, O'Dwyer ST, Shalet SM.

J Clin Endocrinol Metab. 2000 Sep;85(9):3402-8.


Single blind, randomised trial of efficacy and acceptability of oral picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening.

Atkin WS, Hart A, Edwards R, Cook CF, Wardle J, McIntyre P, Aubrey R, Baron C, Sutton S, Cuzick J, Senapati A, Northover JM.

BMJ. 2000 Jun 3;320(7248):1504-8; discussion 1509.


Improving the cost-effectiveness of colorectal cancer screening.

Atkin WS, Whynes DK.

J Natl Cancer Inst. 2000 Apr 5;92(7):513-4. No abstract available.


Increasing the reach of flexible sigmoidoscopy.

Bell GD, Atkin WS, Painter J, Rowland RS, Dogramadzi S, Allen C.

Endoscopy. 1999 Nov;31(9):835-6. No abstract available.


Supplemental Content

Loading ...
Support Center